Tsfg, LLC Sage Therapeutics, Inc. Transaction History
Tsfg, LLC
- $489 Million
- Q1 2025
A detailed history of Tsfg, LLC transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Tsfg, LLC holds 75 shares of SAGE stock, worth $537. This represents 0.0% of its overall portfolio holdings.
Number of Shares
75Holding current value
$537% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding SAGE
# of Institutions
191Shares Held
44.9MCall Options Held
304KPut Options Held
117K-
Black Rock Inc. New York, NY5.22MShares$37.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.84MShares$34.7 Million0.0% of portfolio
-
Morgan Stanley New York, NY4.59MShares$32.9 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V84.46MShares$32 Million0.48% of portfolio
-
Rtw Investments, LP New York, NY3MShares$21.5 Million0.27% of portfolio
About Sage Therapeutics, Inc.
- Ticker SAGE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,422,300
- Market Cap $426M
- Description
- Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...